Navigation Links
Transforming Next Generation Medicines through Novel Bioavailabity & Bioequivalence Approaches
Date:8/5/2014

Los Angeles, CA (PRWEB) August 05, 2014

Speaking for this occasion, CEO of the OMICS Group International, Dr. Srinubabu Gedela observed that several high profile speakers from reputed companies include Sinerik Ayrapetyan, UNESCO, Armenia; Lakshmi Putcha, NASA-Johnson Space Center, USA; Chase Bourke, USFDA, USA; Shnaukshta Valentina, Ministry Of Health Of The Republic of Kazakhstan; Sid Bhoopathy, Absorption Systems, USA; De Backer JW, FLUIDDA, Belgium; Luigi Silvestro, 3S-Pharmacological Consultation & Res, Germany; Sattam Al Ghodyyr, FDA, Saudia Arabia; Lisa Murray, Absorption Systems, USA; Jim Jingjun Huang, Ascendia Pharmaceuticals, LLC, USA; Kanat Khazhidinov, scientific center for anti-infective drugs, Kazakhstan who are attending this conference to share their experience at BABE-2014.

The eminent expert speakers at this International Pharma Conference include Braddy April, FDA, USA; Sean Zhang, Sino-American Pharmaceutical, USA; Myung Park, University of Maryland, USA; Laszlo Endrenyi, University of Toronto, Canada; An Songon, University of Maryland USA; Wolfgang Sadee, Ohio State University, SA; Diane J Burgess, University of Connecticut, USA; Christian Schoeneich, University of Kansas, USA; Jennifer Hibbs, Sullivan University, USA; Tania Konry, North-eastern University, USA; Chertok Beata, University of Michigan, USA; Smith David, University of Michigan, USA; Marino John P, National Institute of Standards and Technology, USA; Jim Jingjun Huang, CEO Ascendia Pharmaceuticals LLC, USA; Chase Bourke, FDA, USA; Salah Blaih, Kent State University, USA; Kaji. Hideko, Thomas Jefferson University, USA; Jan Sieluk, University of Maryland, USA; Palmer Taylor, Skaggs School of Pharmacy, USA; Joshua P. Lorenz, University of Cincinnati, USA; Sungchul Ji, State University of New York, USA; H.P. Vasantha Rupasinghe, Dalhousie University, USA.

Important tracks that are part of this scientific meeting includes Emerging Bioavailability and Bioequivalence Studies, Bioanalytical Methodology, Contemporary Challenges of Drug Design, Discovery and Development, Regulatory Policies, Procedures and Prerequisites for Clinical Research, Managing BA/BE Studies Relevance of Genetics to BA/BE in Drug Development, Bioavailability, Bioequivalence and Drug Product Selection, Advances in Assessment of Bioequivalence, Need for Conducting BA/BE Studies, Metabolic Pathways and Changes in Nutrient Bioavailability, Clinical Pharmacokinetics, Clinical Pharmacology and Therapeutics, Translational Cancer Research and Anticancer Drug Discovery, and Chronopharmaceutics: Germane Approach to Drug Delivery.

OMICS Group International is an open access publisher with 400 online peer reviewed science journals in the fields of Clinical, Medical, Engineering and technological, Pharmaceutical and Management fields. OMICS group hosts more than 300 International conferences and events across the globe. With the help of more than 1000 scientific associations. OMICS Group has been involved in providing a momentous platform for the world renowned scientists, researchers and talented student community from academic institutions to participate in the best academic conferences in the globe along with the collaboration initiatives with the leading entrepreneurs from industries.

Lambda Therapeutics Research Limited is a supporting silver sponsor for 5th World Congress on Bioavailability and Bioequivalence: Pharmaceutical R&D Summit, which is to be held during September 29 to October 01, 2014 at Baltimore, USA

To know more about the eminent speakers who will mark their presence at this conference, kindly visit our scientific program

For any further information please contact

John Benson
BABE-2014 Organizing Committee
Pharmaceutical Conferences
5716 Corsa Ave Suite110
Westlake Los Angeles
CA-91362-7354 USA
Ph: +1-888-843-8169
Toll No +1-800-216-6499
E-mail: babe2014(at)omicsonline.us

Read the full story at http://www.prweb.com/releases/OMICS-Group-International/BABE-2014/prweb12069099.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Transforming America by redirecting wasted health care dollars
2. Scott Sheldon Unveils New Web Design: Transforming Supply Chains
3. Colorado Takes a Huge Step toward Transforming the Family Dining Experience
4. New Logo Better Communicates Niche of Scott Sheldon, LLC: Transforming Supply Chains
5. Trivedi Masters Invite People across the Globe for the Historic Event, 'TRANSFORMING HUMANITY'
6. Transforming the physician workforce through competitive graduate education funding
7. Mahendra Trivedi Announces the New Master During the Historical Event “Transforming Humanity”
8. Transforming Recipes: Review Examines Alex Navarro and Mary J Gines' New Ultra Low-Carb Recipe Book
9. NIH awards $20 million over 5 years to train next generation of global health researchers
10. Innovation Generation
11. Interpreting the Avastin-Lucentis study for persons with macular degeneration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... ... its strategic partnership with Connance, a healthcare industry leader providing predictive analytics ... proprietary technology combine to provide health systems, hospitals and ambulatory surgical centers ...
(Date:6/26/2016)... , ... June 26, 2016 , ... Pixel Film Studios ... X. , "Film editors can give their videos a whole new perspective by using ... - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 Different ...
(Date:6/25/2016)... , ... June 25, 2016 , ... Austin residents seeking ... American College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical ... effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by ...
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell ... pain and the benefits of holistic treatments, Serenity Recovery Center of Marne, ... Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... June 24, 2016 The Academy of Managed ... recommendations that would allow biopharmaceutical companies to more ... that make formulary and coverage decisions, a move that ... new medicines. The recommendations address restrictions in ... on the drug label, a prohibition that hinders decision ...
(Date:6/24/2016)... PUNE, India , June 24, 2016 ... "Pen Needles Market by Type (Standard Pen Needles, Safety ... 12mm), Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase ... published by MarketsandMarkets, This report studies the market for ... is expected to reach USD 2.81 Billion by 2021 ...
Breaking Medicine Technology: